Home / Market News / $PGNY
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

JP Morgan Raises Progyny Price Target to $35

Nov 9, 2026, 11:09 PM UTC · Primary ticker $PGNY

JP Morgan has increased its price target for Progyny from $30 to $35, while maintaining a 'Neutral' rating. This adjustment brings the target in line with the company's recent trading price and reflects broader analyst sentiment, indicating a moderate positive signal for the stock.

JP Morgan, a prominent financial institution, raised its price target for Progyny (PGNY) from $30 to $35. This action, while maintaining a 'Neutral' rating, signals a slightly more optimistic outlook from the analyst. The new target aligns closely with Progyny's recent closing price, suggesting that the market has largely already priced in this valuation. For traders, this indicates a moderate positive sentiment, but the 'Neutral' rating suggests limited immediate upside potential based on this specific analyst action. The short-term implication is a potential stabilization or slight upward pressure on the stock, but long-term implications are less clear without a change in rating.

$PGNY positive Price target increase
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.